NCT00191880已完成3 期
A Phase IIIb Open-Label Trial of Atomoxetine Hydrochloride to Evaluate Academic Outcome in Children Ages 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 8
- 主要终点
- The primary objective of this study is to assess the correlation of change from baseline to one year in ADHD symptoms as measured by the Attention Deficit/Hyperactivity Disorder Rating Scale- IV-
研究概览
简要总结
Open-label trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 years with Attention- Deficit/Hyperactivity Disorder
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 8 Years 至 11 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have ADHD, be psychotropic medication naive and be outpatients who are at least 8 years of age and not more than 10 years of age at Visit 1 (that is, not yet reached their 11 birthday) so that all year testing will be completed before the child reaches age 12.
排除标准
- •Patients with current or past history of Bipolar I or II disorder, psychosis, autism, Asperger's syndrome, pervasive developmental disorder, conduct disorder, seizure disorder or serious suicidal risk are excluded
结局指标
主要结局
The primary objective of this study is to assess the correlation of change from baseline to one year in ADHD symptoms as measured by the Attention Deficit/Hyperactivity Disorder Rating Scale- IV-
Parent Version: Investigator Administered and Scored,
total score, with change from baseline in academic achievement of medication-naive patients treated with atomoxetine at one year as measured by the total
of the composite scores of the broad reading, broad math, and broad language subtests of the Woodcock-Johnson Tests of Achievement (WJII)
次要结局
- To Assess the correlation of change from baseline to one year or at study discontinuation in ADHD symptoms as measured by the ADHDRS-IV-Parent:Inv with change from baseline with each of the academic achievement composite scores of the broad reading, broa
研究者
研究点 (8)
Loading locations...
相似试验
已完成
3 期
Long-Term, Open Label Atomoxetine StudyAttention Deficit Hyperactivity DisorderNCT00190684Eli Lilly and Company1,553
已完成
3 期
Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsAttention Deficit Hyperactivity DisorderNCT00191659Eli Lilly and Company200
终止
4 期
Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALLAttention Deficit Hyperactivity DisorderNCT00299234Monarch Medical Research1
已完成
4 期
Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHDAttention-Deficit/Hyperactivity DisorderComorbid DyslexiaNCT00191048Eli Lilly and Company105
已完成
4 期
A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASDAttention Deficit Hyperactivity DisorderNCT00485849Eli Lilly and Company12